NASDAQ:QXL

Quantum X Labs Shares Edge Up After New CliniQuantum Info as Markets Wait on Cash Update
····

Quantum X Labs Shares Edge Up After New CliniQuantum Info as Markets Wait on Cash Update

Quantum X Labs shares rose 2.7% to $4.26 Wednesday after NeuroThera disclosed new details on a CliniQuantum license deal involving Quantum X’s technology. The company named Technion professor Oren Kurland to its new scientific advisory board. Quantum X remains early-stage and flagged a going-concern risk in filings. Trading volume stayed thin at 27,676 shares.
May 27, 2026

Stock Market Today

  • Rolls-Royce Shares Down 5.9% Over 3 Months: £1,000 Investment Now Worth £941
    May 27, 2026, 1:02 PM EDT. Rolls-Royce (LSE: RR.) shares fell 5.9% in three months, sliding from 1,386p to about 1,248p. A £1,000 investment three months ago would now be worth around £941, reflecting a £59 loss. The decline reflects geopolitical tensions impacting civil aviation, including US-Iran conflicts raising fuel supply concerns. Despite this, Rolls-Royce forecasts revenue growth from £22.7 billion this year to £27.54 billion by 2028, aided by business diversification beyond civil aviation. The stock trades at a moderate 18 P/E (price-to-earnings ratio), suggesting less valuation stretch compared to many growth stocks. Alternatives like AstraZeneca, valued at a 41.8% discount via discounted cash flow models but facing patent risks, and British American Tobacco also merit investor attention for growth and income potential.